1. Home
  2. OCUL vs SPNT Comparison

OCUL vs SPNT Comparison

Compare OCUL & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • SPNT
  • Stock Information
  • Founded
  • OCUL 2006
  • SPNT 2011
  • Country
  • OCUL United States
  • SPNT Bermuda
  • Employees
  • OCUL N/A
  • SPNT N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • SPNT Property-Casualty Insurers
  • Sector
  • OCUL Health Care
  • SPNT Finance
  • Exchange
  • OCUL Nasdaq
  • SPNT Nasdaq
  • Market Cap
  • OCUL 2.3B
  • SPNT 2.4B
  • IPO Year
  • OCUL 2014
  • SPNT N/A
  • Fundamental
  • Price
  • OCUL $12.24
  • SPNT $19.79
  • Analyst Decision
  • OCUL Strong Buy
  • SPNT Buy
  • Analyst Count
  • OCUL 10
  • SPNT 3
  • Target Price
  • OCUL $22.33
  • SPNT $24.00
  • AVG Volume (30 Days)
  • OCUL 2.1M
  • SPNT 523.0K
  • Earning Date
  • OCUL 11-04-2025
  • SPNT 10-30-2025
  • Dividend Yield
  • OCUL N/A
  • SPNT N/A
  • EPS Growth
  • OCUL N/A
  • SPNT N/A
  • EPS
  • OCUL N/A
  • SPNT 1.45
  • Revenue
  • OCUL $55,783,000.00
  • SPNT $2,859,100,000.00
  • Revenue This Year
  • OCUL N/A
  • SPNT $0.89
  • Revenue Next Year
  • OCUL $17.75
  • SPNT $6.87
  • P/E Ratio
  • OCUL N/A
  • SPNT $13.60
  • Revenue Growth
  • OCUL N/A
  • SPNT 6.92
  • 52 Week Low
  • OCUL $5.79
  • SPNT $13.26
  • 52 Week High
  • OCUL $13.85
  • SPNT $21.03
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 59.26
  • SPNT 58.55
  • Support Level
  • OCUL $11.08
  • SPNT $19.72
  • Resistance Level
  • OCUL $12.03
  • SPNT $20.54
  • Average True Range (ATR)
  • OCUL 0.53
  • SPNT 0.55
  • MACD
  • OCUL 0.13
  • SPNT 0.03
  • Stochastic Oscillator
  • OCUL 89.86
  • SPNT 72.13

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: